Actively Recruiting

All Genders
ID05153694

Infectious Complications After Cystectomy: A Prospective Observational Study

Led by Ludwig-Maximilians - University of Munich · Updated on 2024-09-19

200

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to better understand infectious complications in patients undergoing cystectomy, which is the surgical removal of the urinary bladder, performed for both cancerous and non-cancerous reasons. The study prospectively collects detailed medical history and clinicopathological data, focusing on markers of infection before and after surgery. It also compares patient-reported and physician-assessed complications, and explores how in-hospital complications relate to quality of life after surgery. Participants undergo cystectomy, and the study monitors inflammatory markers like interleukin-6 and procalcitonin, as well as wound drainage cultures, to evaluate early signs of infection. Researchers also compare infection rates between different types of urinary diversion surgeries, such as ileal neobladder versus ileal conduit. Follow-up periods extend up to 12 months after surgery to assess infectious complications and their impact. Participants are involved through structured follow-up interviews at 3, 6, and 12 months post-surgery, which use standardized questionnaires to record post-discharge infections and patient experiences in the hospital. The study carefully tracks in-hospital complications, antibiotic use, fever episodes, emergency visits, and hospital readmissions. Outcomes also include quality of life assessments and subjective ratings of preoperative information and complications, providing a comprehensive view of patient health and recovery over time.

CONDITIONS

Brief Title

Infectious Complications After Cystectomy: A Prospective Observational Study

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Disease which requires removal of the urinary bladder
Not Eligible

You will not qualify if you...

  • Patient does not want to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Surgery day through hospital discharge

Participants undergo cystectomy surgery followed by hospital stay for monitoring of infectious complications and in-hospital outcomes.

1 surgical procedure and daily hospital visits until discharge

Post-operative Follow-up

Duration - Up to 12 months after discharge

Participants are monitored for infectious complications, antibiotic use, and quality of life up to 12 months after discharge.

Periodic follow-up visits during the first year after discharge

Trial Site Locations

Total: 1 location

1

Urology Department - LMU Klinikum

Munich, Outside U.S./Canada, Germany, 81377

Actively Recruiting

Loading map...

Research Team

B

Benedikt Ebner, Dr.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therap...

Benign Prostatic Hyperplasia

Actively Recruiting

1 location

A Phase 1/2 Open Label, Dose Escalation and Expansion Study ...

Advanced Solid Tumor

Actively Recruiting

27 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Prospective Evaluation of Blood-based and Microbiological Early Indicators of In-hospital Infectious Complications After Open Cystectomy.

Benedikt Ebner, Judith Hirsch, Annkathrin Holz...

https://pubmed.ncbi.nlm.nih.gov/41334533

Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma.

Benedikt Ebner, Judith Hirsch, Annkathrin Holz...

https://pubmed.ncbi.nlm.nih.gov/41006129

Discrepancies between physician-assessed and patient-reported complications after cystectomy - a prospective analysis.

Benedikt Ebner, Judith Hirsch, Annkathrin Holz...

https://pubmed.ncbi.nlm.nih.gov/39928165